A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents
Clinical trial NCT04530110 · COMPLETED
Trial details
- NCT number
- NCT04530110
- Sponsor
- Teva Branded Pharmaceutical Products R&D LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-16
- Primary completion
- 2025-08-15
- Enrollment
- 499
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.